These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22962914)

  • 21. Clopidogrel and proton pump inhibitors: a clinically meaningful interaction?
    Gerhard T
    Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):214-8. PubMed ID: 21254294
    [No Abstract]   [Full Text] [Related]  

  • 22. [Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?].
    Lanas A
    Gastroenterol Hepatol; 2010 Jan; 33(1):1-5. PubMed ID: 20005015
    [No Abstract]   [Full Text] [Related]  

  • 23. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for recurrence of clostridium difficile-associated diarrhoea.
    Samie AA; Traub M; Bachmann K; Kopischke K; Theilmann L
    Hepatogastroenterology; 2013 Sep; 60(126):1351-4. PubMed ID: 23262313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPI interactions with clopidogrel.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):2-3. PubMed ID: 19122567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitors.
    Saiz LC; Alvarez J; Martínez H
    Am J Gastroenterol; 2011 Jul; 106(7):1369-70. PubMed ID: 21731026
    [No Abstract]   [Full Text] [Related]  

  • 31. Clopidogrel and proton pump inhibitor use: what does the evidence really say?
    Baker WL; Coleman CI; Lundbye JB
    Conn Med; 2010 Jan; 74(1):27-31. PubMed ID: 20175370
    [No Abstract]   [Full Text] [Related]  

  • 32. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 35. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflux drugs linked to C. difficile-related diarrhea.
    Kuehn BM
    JAMA; 2012 Mar; 307(10):1014. PubMed ID: 22416090
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors: Clostridium difficile infections.
    Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?].
    Ter Arkh; 2011; 83(10):68-71. PubMed ID: 22185030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
    Hauben M; Horn S; Reich L; Younus M
    Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.